Observational cohort study of rilpivirine (RPV) utilization in Europe

Autor: Cozzi-Lepri, Alessandro, Peters, Lars, Pelchen-Matthews, Annegret, Neesgaard, Bastian, de Wit, Stephane, Johansen, Isik Somuncu, Edwards, Simon, Stephan, Christoph, Adamis, Georgios, Staub, Therese, Zagalo, Alexandra, Domingo, Pere, Elbirt, Daniel, Kusejko, Katharina, Brännström, Johanna, Paduta, Dzmitry, Trofimova, Tatyana, Szlavik, Janos, Zilmer, Kai, Losso, Marcello, van Eygen, Veerle, Pai, Helen, Lundgren, Jens, Mocroft, Amanda, Harxhi, A., Losso, M., Kundro, M., Schmied, B., Karpov, I., Vassilenko, A., Paduto, D., Mitsura, V. M., Clumeck, N., de Wit, S., Delforge, M., Hadziosmanovic, V., Begovac, J., Machala, L., Jilich, D., Gerstoft, J., Pedersen, C., Sedlacek, D., Kronborg, G., Benfield, T., Johansen, I. S., Ostergaard, L., Wiese, L., Moller, N. F., Nielsen, L. N., Zilmer, K., Smidt, Jelena, Aho, I., Viard, J. P., Girard, P. M., Pradier, C., Fontas, E., Duvivier, C., Rockstroh, J., Degen, O., Hoffmann, C., Stellbrink, H. J., Stefan, C., Bogner, J., Fätkenheuer, G., Chkhartishvili, N., Sambatakou, H., Adamis, G., Paissios, N., Uzdaviniene, V., Staub, T., Dragas, S., Reiss, P., Trajanovska, J., Reikvam, D. H., Maeland, A., Bruun, J., Knysz, B., Szetela, B., Inglot, M., Bakowska, E., Flisiak, R., Grzeszczuk, A., Parczewski, M., Maciejewska, K., Aksak-Was, B., Beniowski, M., Mularska, E., Jablonowska, E., Kamerys, J., Wojcik, K., Mozer-Lisewska, I., Rozplochowski, B., Zagalo, A., Radoi, R., Oprea, C., Yakovlev, A., Trofimora, T., Khromova, I., Kuzovatova, E., Borodulina, E., Vdoushkina, E., Ranin, J., Tomazic, J., Miro, J. M., Laguno, M., Martinez, E., Garcia, F., Blanco, J. L., Martinez-Rebollar, M., Mallolas, J., Callau, P., Rojas, J., Moreno, S., del Campo, S., Jou, A., Paredes, R., Puig, J., Llibre, J. M., Santos, J. R., Domingo, P., Gutierrez, M., Mateo, G. M., Sambeat, A., Laporte, J. M., Svedhem, V., Thalme, A., Sonnerborg, A., Flamholc, L., Kusejko, K., Weber, R., Calmy, A., Furrer, H., Battegay, M., Schmid, P., Kuznetsova, A., Mikhalik, J., Sluzhynska, M., Milinkovic, A., Johnson, A. M., Simons, E., Edwards, S., Phillips, A. M., Johnson, A., Mocroft, A., Orkin, C., Winston, A., Clarke, A., Leen, C., Study group members AMC, van der Valk, Marc

Publikováno v: Cozzi-Lepri, A, Peters, L, Pelchen-Matthews, A, Neesgaard, B, De Wit, S, Johansen, I S, Edwards, S, Stephan, C, Adamis, G, Staub, T, Zagalo, A, Domingo, P, Elbirt, D, Kusejko, K, Brännström, J, Paduta, D, Trofimova, T, Szlavik, J, Zilmer, K, Losso, M, Van Eygen, V, Pai, H, Lundgren, J, Mocroft, A & for the EuroSIDA Study Group 2022, ' Observational cohort study of rilpivirine (RPV) utilization in Europe ', AIDS Research and Therapy, vol. 19, no. 1, 38 . https://doi.org/10.1186/s12981-022-00457-0
for the EuroSIDA study group 2022, ' Observational cohort study of rilpivirine (RPV) utilization in Europe ', AIDS Research and Therapy, vol. 19, no. 1, 38 . https://doi.org/10.1186/s12981-022-00457-0
AIDS research and therapy, 19:38. BioMed Central

Introduction Data on safety and effectiveness of RPV from the real-world setting as well as comparisons with other NNRTIs such as efavirenz (EFV) remain scarce. Methods Participants of EuroSIDA were included if they had started a RPV- or an EFV-conta

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7573bb96c996b2e99419c4a2aee0d010
https://doi.org/10.1186/s12981-022-00457-0

Cabotegravir/rilpivirine (Cabenuva) for HIV-1 infection.

Publikováno v: The Medical letter on drugs and therapeutics [Med Lett Drugs Ther] 2021 May 31; Vol. 63 (1625), pp. 81-83.

Tenofovir alafenamide (TAF) as the successor of tenofovir disoproxil fumarate (TDF).

Autor: De Clercq E; KU Leuven, Department of Microbiology and Immunology, Rega Institute for Medical Research, Minderbroedersstraat 10, B-3000 Leuven, Belgium. Electronic address: erik.declercq@kuleuven.be.

Publikováno v: Biochemical pharmacology [Biochem Pharmacol] 2016 Nov 01; Vol. 119, pp. 1-7. Date of Electronic Publication: 2016 Apr 29.